Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Modified vaccinia Ankara - Bavarian Nordic

Next Previous
Drug Profile

Modified vaccinia Ankara - Bavarian Nordic

Alternative Names: IMVAMUNE; IMVAMUNE® liquid-frozen; IMVAMUNE® freeze-dried; IMVANEX; JYNNEOS; Monkeypox vaccine - Bavarian Nordic; MVA-BN; MVA-BN® Smallpox; MVA-BN® freeze-dried; MVA-BN® liquid-frozen; MVA-BN® smallpox vaccine; Smallpox and monkeypox vaccine - Bavarian Nordic

Latest Information Update: 02 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bavarian Nordic
  • Developer Bavarian Nordic; Centers for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; National Institutes of Health (USA)
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Monkeypox; Smallpox; Vaccinia virus infections

Most Recent Events

  • 29 May 2025 Phase-III clinical trials in Monkeypox (In infants, Prevention) in Democratic Republic of the Congo (SC) (NCT06844487)
  • 23 May 2025 Bavarian Nordic initiates a Phase-III clinical trials in Monkeypox ( Prevention) in Democratic Republic of the Congo (SC) (NCT06844500)
  • 06 May 2025 Bavarian Nordic plans manufacturing and supply of Modified vaccinia Ankara to USA in 2026

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top